Skip to main content
Figure 3 | Journal of NeuroEngineering and Rehabilitation

Figure 3

From: Facilitatory effects of anti-spastic medication on robotic locomotor training in people with chronic incomplete spinal cord injury

Figure 3

Peak velocity (Vp) during dorsiflexion in the combined locomotor treadmill training (LTT; blue) and Tizanidine (TizLTT; red) group. (a) Mean (SEM) at 0, 1, 2 and 4 weeks into the intervention and (b) change in Vp plotted against change in walking speed from baseline to the 4th week assessment, for subjects in the TizLTT group that did (filled diamonds) and did not (open diamonds) achieve the minimal important difference (MID) in the 10MWT.

Back to article page